Sorrento TherapeuticsSRNE
13F holders, Q2 2025 (June 30)2holders −2
0new positions
2sold out
$0.00avg. 13F price*
At the end of Q2 2025, 2 institutions reported holding Sorrento Therapeutics Inc. (SRNE) in their 13F filings, down 2 from Q1 2025. 0 opened new positions and 2 sold out. The largest holders were Huntington National Bank ($6) and Financial Gravity Companies, Inc. ($0).
- Company
- Sorrento Therapeutics Inc.
- CUSIP
- 83587F202
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 2 | $0 |
All 13F filers, Q1 2025 → Q2 2025: 1,070 shares sold, net −1,070 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| Huntington National Bank | 0.00% | No change | 5,001 | $6 |
| Financial Gravity Companies, Inc. | 0.00% | — | 18 | $0 |
"% of holder's portfolio" is SRNE's weight in each manager's 13F, not the share of Sorrento Therapeutics Inc. the manager owns.